Hear Atlast Holdings Inc(HRAL)
USD --+0.00%
Reward63Moderate
Risk35Moderate
📊75%Data
Strong 76% profit margin · Revenue growing 255% YoY
HRAL
+0.0 · +0.00%
USD · PINK
Hear Atlast Holdings Inc | Healthcare
Profitless Growth
Market Cap:203464
ℹ️
Reward Rating
63
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
35
Moderate
Risk Assessment
75% data coverage
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on HRAL to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Hear Atlast Holdings Inc?

operates hearing clinics in North America.

HRAL · Verdict

Solid reward · moderate risk

HRAL stands out on volatility and growth, but watch the profitability signal.

Based on 75% data coverage

HRAL · Verdict

What’s working & what to watch

Strengths 3

  • Volatility95/100

    Top decile vs peers

  • Growth87/100

    Top decile vs peers

  • Balance sheet69/100

    Net debt/EBITDA 0.0×

Watchouts 1

  • Profitability33/100

    0% return on equity

Model-based scoring. For information only — not financial advice.

What is Hear Atlast Holdings Inc?

operates hearing clinics in North America. The company offers hearing assessments and hearing instruments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 203.46K.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (63)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap203.46K
P/E Ratio0.0023
Dividend YieldN/A
52 Week High0.0007
52 Week Low0.0003
Last AnnualMarch
IPO DateN/A
IncorporatedUSA
Shares Outstanding509M
No. of EmployeesN/A
IndustryMedical Instruments & Supplies
ExchangePINK
Beta0.247
CurrencyUSD